Industry Group Advises Manufacturers On Quantifying Risks of Raw Materials Used In Advanced Therapy Medicinal Products
Executive Summary
A concept paper prepared by an EU industry group is designed to help manufacturers conduct risk assessment for raw materials used in advanced therapy medicinal products (ATMPs) and biopharmaceutical products.